Oxygen Therapy, Inc. — Form D
Oxygen Therapy, Inc. of NEWTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-09-27. The offering totals $1.0M, of which $300K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-09-27
- Form: D
- Accession: 0001685616-16-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $300K
- Remaining: $700K
- Minimum investment: $10K
- Investors: 12
- Date of first sale: 2016-08-19
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-271332
Issuer
- Name: Oxygen Therapy, Inc.
- CIK: 0001685616
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 233 NEEDHAM STREET, NEWTON, MA, 02464
- Phone: 617-454-1199
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| David Platt | Director | Atglen, PA |
| David Platt | Executive Officer | Atglen, PA |
| Ola Soderquist | Director | New York, NY |
| Ola Soderquist | Executive Officer | New York, NY |
| Henry J Esber | Director | Newton, MA |
| Dale H Conaway | Director | Newton, MA |
| Alan J Hoberman | Director | Newtown, MA |
| Yuval Kwintner | Director | Newton, MA |
| Yuval Kwintner | Executive Officer | Newton, MA |
Other filings by this issuer (1)
More